Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study
<p><strong>Background</strong></p> Four decades into the HIV epidemic, CNS infection remains a leading cause of preventable HIV-related deaths in routine care. The Driving Reduced AIDS-associated Meningo-encephalitis Mortality (DREAMM) project aimed to develop, implement, and...
Main Authors: | Mfinanga, S, Kanyama, C, Kouanfack, C, Fuller, S |
---|---|
מחברים אחרים: | DREAMM Consortium |
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Elsevier
2023
|
פריטים דומים
-
Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study
מאת: Anna Cardellino, et al.
יצא לאור: (2023-12-01) -
P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY
מאת: A. Suvannasankha, et al.
יצא לאור: (2022-06-01) -
Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa: Field notes from Uganda
מאת: Faith Moyo, et al.
יצא לאור: (2023-08-01) -
P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA
מאת: S. Z. Usmani, et al.
יצא לאור: (2022-06-01) -
CNS Involvement in HIV Infection
מאת: J Gordon Millichap
יצא לאור: (1991-08-01)